Eli Lilly, Genf: Neue orale Therapieoption in der rheumatoiden Arthritis (RA)
- 0 minute read
You May Also Like
- Geriatric patients
Micronutrient Intake in Older Adults
- Crohn's disease: focus on long-term results
“Top-down” approach or classic step therapy?
- SwissDiab Study: New Analysis Published
How are diabetes complications associated with quality of life?
- Pre-acclimatization on Mount Everest
Exploring the physiological limits
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry
Rituximab used effectively against IgG4-RD colitis
- Sarcoidosis